BioTime (BTX) Misses Q2 EPS by 3c

BioTime (NYSE: BTX) reported Q2 EPS of ($0.11), $0.03 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $381 thousand versus the consensus estimate of $470 thousand.

For earnings history and earnings-related data on BioTime (BTX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• S&P 500 eyes record as retail slump, Iran risk set up pivotal week